We found that RARRES1 was significantly reduced in SKCM patients of T4 stage, pathological stage II, age over 60, with melanoma ulcer, higher Clark level, higher Breslow thickness and without radiotherapy (Fig. 1B-H), indicating decreased RARRES1 expression was associated with poor clinical features of SKCM. Here, RARRES1 is linked to melanoma.